— Know what they know.
Not Investment Advice
Also trades as: AYR-A.CN (CNQ) · $vol 0M

AYRWF OTC

Ayr Wellness Inc.
1W: +0.0% 1M: +0.0% 3M: -75.3% YTD: -82.6% 1Y: -84.9% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $432062 mcap · 93M float · 0.202% daily turnover · Short 27% of daily vol

Cash Flow Trends

Operating Cash Flow
$10M -64.5% ▼
5Y CAGR: +21.9%
Capital Expenditures
$25M +37.5% ▲
5Y CAGR: +11.4%
Free Cash Flow
-$15M -21.7% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$283K +22.7% ▲
Net Change in Cash
-$15M +48.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$176M-$17M-$255M-$276M-$362M
Depreciation & Amort.$18M$59M$93M$91M$86M
Stock-Based Comp.$31M$27M$47M$16M$18M
Change in Working Capital$9M-$42M-$8M$40M$52M
Other Non-Cash Items$152M-$39M$91M$163M$230M
Operating Cash Flow$37M-$28M-$34M$27M$10M
— Investing Activities —
Capital Expenditures-$15M-$100M-$62M-$38M-$18M
Acquisitions (Net)-$47M-$119M-$17M-$4M$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$50K-$1M$13M$18M-$4M
Investing Cash Flow-$62M-$220M-$66M-$24M-$22M
— Financing Activities —
Net Debt Issuance$98M$133M$23M-$52M$8M
Stock Repurchased-$311K-$2M-$8M-$366K-$283K
Dividends Paid$0$0$0$0$0
Other Financing$47M$25M$17M$19M-$11M
Financing Cash Flow$145M$275M$27M-$33M-$3M
Net Change in Cash$119M$27M-$74M-$30M-$15M
Cash End of Period$127M$154M$81M$51M$35M
Free Cash Flow$22M-$128M-$97M-$12M-$15M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms